These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 332344)

  • 1. Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.
    Portlock CS; Rosenberg SA
    Cancer Treat Rep; 1977 Sep; 61(6):1049-55. PubMed ID: 332344
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
    Coltman CA; Luce JK; McKelvey EM; Jones SE; Moon TE
    Cancer Treat Rep; 1977 Sep; 61(6):1067-78. PubMed ID: 71206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of B-cell non-Hodgkin's malignant lymphomas of childhood in Europe: recent and on-going studies.
    Lemerle J
    IARC Sci Publ; 1985; (60):383-98. PubMed ID: 3905590
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of non-Hodgkin lymphomas].
    Izzi T; Porcellini A; Delfini C; Lucarelli G
    Minerva Med; 1982 Apr; 73(15):949-53. PubMed ID: 7078792
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials in the non-Hodgkin's lymphomata at Stanford University experimental design and preliminary results.
    Rosenberg SA; Kaplan HS
    Br J Cancer Suppl; 1975 Mar; 2():456-64. PubMed ID: 1101931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
    Case DC
    J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW
    Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I.
    Heinz R; Pawlicki M; Losonczy H; Varbiro M; Benedek S; Konopka L; Krc I; Brugiatelli M
    Haematologica; 1986; 71(6):473-9. PubMed ID: 3104156
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary analysis of results of chemotherapy in patients with proliferative disease of the lymphatic system with the exclusion of Hodgkin's disease using vincristine, cyclophosphamide and prednisone].
    Zelechowska JA; Leszczyk C; Madej G; Pieńkowska F; Nozdryn-Plotnicki B
    Pol Tyg Lek; 1977 Aug; 32(34):1329-31. PubMed ID: 905177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
    Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
    Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
    [No Abstract]   [Full Text] [Related]  

  • 19. The need of adequate staging and aggressive therapy in non-Hodgkin's lymphomas. Report of 66 cases.
    Johansson RT; Joensuu H
    Strahlentherapie; 1983 Feb; 159(2):104-8. PubMed ID: 6836627
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of malignant lymphoma with adriamycin.
    Gottlieb JA; Gutterman JU; McCredie KB; Rodriguez V; Frei E
    Cancer Res; 1973 Nov; 33(11):3024-8. PubMed ID: 4748450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.